Tuesday, June 16, 2026

Policy

Policy•Fierce Biotech•Jun 15, 2026

Intellia touts ‘paradigm-shifting’ phase 3 data for one-time HAE treatment

background ▾

• •Intellia touts ‘paradigm-shifting’ phase 3 data for one-time HAE treatment

→ Read original article

Policy•Fierce Biotech•Jun 15, 2026

Amgen loses in Harbour antibody patent case, ordered to pay $20M+

background ▾

• •Amgen loses in Harbour antibody patent case, ordered to pay $20M+

→ Read original article

Policy•Fierce Biotech•Jun 15, 2026

Spyre spies another edge for UC ambitions with midstage win for anti-TL1A antibody

background ▾

• •Spyre spies another edge for UC ambitions with midstage win for anti-TL1A antibody

→ Read original article

Policy•KFF•Jun 16, 2026

Bench to Bedside at AI Speed

background ▾

• •Bench to Bedside at AI Speed

→ Read original article

Policy•STAT News•Jun 16, 2026

Opinion: Congress must reauthorize the Pandemic and All-Hazards Preparedness Act

background ▾

• •Opinion: Congress must reauthorize the Pandemic and All-Hazards Preparedness Act

→ Read original article

Market Access

No articles for this category on this date.

Clinical Trials

No articles for this category on this date.